Carol R. Bradford
#88,018
Most Influential Person Now
US otolaryngologist
Carol R. Bradford's AcademicInfluence.com Rankings
Carol R. Bradfordphilosophy Degrees
Philosophy
#9276
World Rank
#12811
Historical Rank
Logic
#6260
World Rank
#7762
Historical Rank
Download Badge
Philosophy
Why Is Carol R. Bradford Influential?
(Suggest an Edit or Addition)According to Wikipedia, Carol R. Bradford is an American otolaryngologist. She is the 15th dean of the Ohio State University College of Medicine and vice president for Health Sciences at the Ohio State University Wexner Medical Center.
Carol R. Bradford's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive genomic characterization of head and neck squamous cell carcinomas (2015) (2860)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. (2008) (619)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. (2002) (470)
- Single‐marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase (2010) (430)
- Clinical predictors of quality of life in patients with head and neck cancer. (2004) (425)
- Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. (2008) (359)
- Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management (2007) (343)
- Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. (2004) (309)
- Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence (2010) (288)
- Genotyping of 73 UM‐SCC head and neck squamous cell carcinoma cell lines (2009) (272)
- Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. (1996) (271)
- Surgical margins in head and neck cancer: A contemporary review (2013) (251)
- Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma (2016) (244)
- Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. (2006) (243)
- COVID‐19 pandemic: Effects and evidence‐based recommendations for otolaryngology and head and neck surgery practice (2020) (237)
- Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. (2011) (226)
- Head and neck cancer-specific quality of life: instrument validation. (1997) (218)
- Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. (1996) (213)
- Pain, Quality of Life, and Spinal Accessory Nerve Status After Neck Dissection (2000) (209)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results (2011) (188)
- Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer (2003) (184)
- The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma (2007) (182)
- The atypical Spitz tumor of uncertain biologic potential (2009) (170)
- P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines (2003) (161)
- Prevention of wound complications following salvage laryngectomy using free vascularized tissue (2007) (158)
- Disability in patients with head and neck cancer. (2004) (158)
- Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. (2005) (156)
- Lean management in academic surgery. (2012) (150)
- Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection (2002) (145)
- Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study. (2001) (145)
- Paranasal Sinus Malignancies: An 18‐Year Single Institution Experience (2002) (144)
- Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. (2010) (140)
- Features predicting sentinel lymph node positivity in Merkel cell carcinoma. (2011) (136)
- A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. (2006) (135)
- Advances and applications of oral cancer basic research. (2011) (134)
- Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. (2005) (134)
- Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review (2016) (132)
- Development and validation of the neck dissection impairment index: a quality of life measure. (2002) (132)
- In vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells (2004) (131)
- Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer (2012) (130)
- Update on primary head and neck mucosal melanoma (2016) (129)
- Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL (2005) (129)
- Stratifying the Risk of Venous Thromboembolism in Otolaryngology (2012) (128)
- Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. (2004) (125)
- (-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. (2006) (124)
- Clinical outcome of continuous facial nerve monitoring during primary parotidectomy. (1997) (124)
- Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. (2007) (123)
- Neuroendocrine neoplasms of the larynx: An overview (2009) (122)
- Sentinel node localization in oral cavity and oropharynx squamous cell cancer. (2001) (120)
- Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. (1999) (120)
- Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. (2010) (119)
- HPV‐positive/p16‐positive/EBV‐negative nasopharyngeal carcinoma in white North Americans (2009) (119)
- Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma (2002) (118)
- Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. (2006) (117)
- Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. (2008) (116)
- Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. (2014) (113)
- Expression of Bcl‐2 Family Proteins in Advanced Laryngeal Squamous Cell Carcinoma: Correlation With Response to Chemotherapy and Organ Preservation (2002) (112)
- The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. (2009) (108)
- Conformal re-irradiation of recurrent and new primary head-and-neck cancer. (2001) (107)
- Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion (2009) (105)
- Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? (2009) (104)
- Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. (2002) (104)
- Overexpression of p53 Predicts Organ Preservation Using Induction Chemotherapy and Radiation in Patients with Advanced Laryngeal Cancer (1995) (104)
- Pectoralis major myocutaneous flap vs revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization. (2004) (104)
- Recurrent Laryngeal Nerve Monitoring in Thyroid and Parathyroid Surgery: The University of Michigan Experience (2003) (101)
- Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate (2015) (99)
- Voice-related quality of life (V-RQOL) following type I thyroplasty for unilateral vocal fold paralysis. (2000) (99)
- Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients (2016) (99)
- High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. (2013) (97)
- UM‐SCC‐104: A New human papillomavirus‐16–positive cancer stem cell–containing head and neck squamous cell carcinoma cell line (2012) (96)
- Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. (2003) (96)
- The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma (2011) (94)
- Copy Number Variations and Clinical Outcome in Atypical Spitz Tumors (2011) (94)
- Leech therapy for patients with surgically unsalvageable venous obstruction after revascularized free tissue transfer. (2002) (92)
- Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. (2005) (91)
- Squamous Cell Carcinoma of the Buccal Mucosa (1999) (91)
- Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. (2010) (89)
- Proposal for a rational classification of neck dissections (2010) (89)
- Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma (2012) (88)
- Impact of Perineural Invasion in the Pathologically N0 Neck in Oral Cavity Squamous Cell Carcinoma (2013) (88)
- Health Impact of Head and Neck Cancer (1999) (85)
- Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer (2008) (85)
- Aspiration pneumonia after chemo–intensity‐modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia‐related predictors (2014) (81)
- Presence of Human Papillomavirus Predicts Ecurrence of Inverted Papilloma (1995) (78)
- Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma (2002) (77)
- Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status (2012) (76)
- Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. (2008) (75)
- The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma (2018) (74)
- Selective Neck Dissection for the Treatment of Neck Metastasis From Squamous Cell Carcinoma of the Head and Neck (2002) (72)
- Inactivation or Loss of TTP Promotes Invasion in Head and Neck Cancer via Transcript Stabilization and Secretion of MMP9, MMP2, and IL-6 (2013) (71)
- Head and neck cancer stem cells: The side population (2011) (71)
- Comparison of ultrasound‐guided core biopsy versus fine‐needle aspiration biopsy in the evaluation of salivary gland lesions (2013) (70)
- p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group. (1997) (70)
- Human papillomavirus types important in progression of inverted papilloma (1995) (70)
- Variables associated with feeding tube placement in head and neck cancer. (2006) (69)
- Free Tissue Reconstruction of the Hypopharynx After Organ Preservation Therapy: Analysis of Wound Complications (2001) (68)
- Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. (2012) (68)
- Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer. (2014) (68)
- Tristetraprolin regulates interleukin‐6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma (2011) (68)
- Primary versus secondary tracheoesophageal puncture in salvage total laryngectomy following chemoradiation (2009) (66)
- Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. (1989) (65)
- Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer. (2014) (65)
- Chemoprophylaxis for venous thromboembolism in otolaryngology. (2014) (65)
- Mucosal melanoma of the head and neck: predictors of prognosis. (2011) (65)
- Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma (1999) (62)
- Cancer stem cells: Mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma (2015) (62)
- Squamous carcinoma of the head and neck in organ transplant recipients: Possible role of oncogenic viruses (1990) (61)
- Sternocleidomastoid muscle flap in preventing Frey's syndrome after parotidectomy: A systematic review (2012) (61)
- Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. (2017) (61)
- Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous Melanoma (2009) (60)
- Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release. (2007) (60)
- Do Micromorphometric Features of Metastatic Deposits Within Sentinel Nodes Predict Nonsentinel Lymph Node Involvement in Melanoma? (2008) (60)
- Human papillomavirus infection in “young” versus “old” patients with squamous cell carcinoma of the head and neck (2000) (59)
- Predictors of Recurrence and Survival for Head and Neck Mucoepidermoid Carcinoma (2013) (59)
- Rectangle tongue template for reconstruction of the hemiglossectomy defect. (2008) (55)
- Head and neck paragangliomas: A two‐decade institutional experience and algorithm for management (2017) (55)
- Reconstruction of Complex Parotidectomy Defects Using the Lateral Arm Free Tissue Transfer (2003) (54)
- Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer. (2005) (52)
- Predictors of pain among patients with head and neck cancer. (2012) (52)
- The Use of a Bovine Collagen Construct for Reconstruction of Full-Thickness Scalp Defects in the Elderly Patient With Cutaneous Malignancy (2005) (51)
- Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma. (2018) (50)
- Management of the facial nerve in parotid cancer: preservation or resection and reconstruction (2018) (50)
- Rap1 Stabilizes β-Catenin and Enhances β-Catenin–Dependent Transcription and Invasion in Squamous Cell Carcinoma of the Head and Neck (2009) (50)
- Genetic and Expression Profiles of Squamous Cell Carcinoma of the Head and Neck Correlate with Cisplatin Sensitivity and Resistance in Cell Lines and Patients (2004) (50)
- Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas. Identification of 2 regions of loss--18q11.1-q12.3 and 18q21.1-q23. (1997) (49)
- Transoral robotic biopsy of the tongue base: A novel paradigm in the evaluation of unknown primary tumors of the head and neck (2013) (49)
- Contemporary management of primary parapharyngeal space tumors (2018) (49)
- Skin cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure. (2009) (49)
- Head and Neck Cancer: A Review of the Impact of Treatment Delay on Outcome (2018) (49)
- Staging workup, sentinel node biopsy, and follow-up tests for melanoma: update of current concepts. (2004) (48)
- Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer. (2006) (48)
- High-Risk Human Papillomavirus Types and Squamous Cell Carcinoma in Patients with Respiratory Papillomas (1995) (48)
- Wide excision without radiation for desmoplastic melanoma (2005) (45)
- Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics (2013) (45)
- Human Papillomavirus DNA Sequences in Cell Lines Derived from Head and Neck Squamous Cell Carcinomas (1991) (45)
- Neoadjuvant Therapy for Organ Preservation in Head and Neck Cancer (2000) (44)
- Parathyroid cancer: An update. (2020) (43)
- Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy (2016) (42)
- Predictive factors in head and neck cancer. (1999) (41)
- Osseocutaneous radial forearm free tissue transfer for repair of complex midfacial defects. (2005) (41)
- Skin cancer of the head and neck with gross or microscopic perineural involvement: Patterns of failure. (2016) (41)
- Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer (2004) (41)
- 11p Deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM‐E7 antibody (1991) (40)
- Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. (2003) (40)
- Patterns of nodal metastasis and prognosis in human papillomavirus–positive oropharyngeal squamous cell carcinoma (2014) (40)
- Biomarkers in advanced larynx cancer (2014) (40)
- Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine (2016) (40)
- Restoration of the Orbital Aesthetic Subunit in Complex Midface Defects (2004) (39)
- Oropharyngoplasty with template-based reconstruction of oropharynx defects. (2009) (39)
- Cartilaginous Tumours of the Larynx (1925) (39)
- Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients? (2016) (38)
- Fibromatosis of the Head and Neck: A Challenging Lesion (2000) (38)
- Analysis of recurrence, complications, and functional results with free jejunal flaps (1994) (38)
- Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog. (2011) (38)
- Hemilaryngectomy for glottic carcinoma after radiation therapy failure. (1994) (38)
- Diagnostic modalities for distant metastasis in head and neck squamous cell carcinoma: Are we changing life expectancy? (2012) (37)
- Improved outcomes in patients with head and neck cancer using a standardized care protocol for postoperative alcohol withdrawal. (2008) (37)
- Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma (2016) (37)
- Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma on the Head and Neck. (2016) (37)
- Expanded tumor-reactive CD4+ T-cell responses to human cancers induced by secondary anti-CD3/anti-CD28 activation. (1999) (37)
- Head and Neck: Editorial (2001) (37)
- Head and neck squamous cell carcinoma of unknown primary: Neck dissection and radiotherapy or definitive radiotherapy (2014) (36)
- Tumor Angiogenesis as a Predictive Marker for Organ Preservation in Patients With Advanced Laryngeal Carcinoma (2002) (36)
- Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma (2017) (35)
- Prognostic importance of surgical margins in advanced laryngeal squamous carcinoma (1996) (35)
- The Utility of Sentinel Lymph Node Biopsy in Head and Neck Melanoma in the Pediatric Population (2003) (35)
- Lateral oromandibular defect: When is it appropriate to use a bridging reconstruction plate combined with a soft tissue revascularized flap? (2008) (35)
- The platysma myocutaneous flap. Indications and caveats. (1994) (35)
- Pretreatment dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas (2012) (35)
- Matted nodes: High distant‐metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus–related oropharyngeal cancer (2016) (34)
- Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. (2005) (34)
- Patient-reported financial toxicity and adverse medical consequences in head and neck cancer. (2019) (34)
- Generation of vaccine‐primed lymphocytes for the treatment of head and neck cancer (2003) (34)
- The management of head and neck melanoma. (2006) (34)
- Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancer (2013) (33)
- Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer. (2007) (32)
- Integration of high‐risk human papillomavirus into cellular cancer‐related genes in head and neck cancer cell lines (2017) (32)
- A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer (2016) (32)
- Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer (2017) (31)
- Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma (2018) (31)
- Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma. (2016) (31)
- Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature. (2019) (31)
- Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma. (2014) (31)
- Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer. (1996) (31)
- A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer (2015) (30)
- Matted nodes as a predictor of distant metastasis in advanced‐stage III/IV oropharyngeal squamous cell carcinoma (2016) (29)
- Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens. (1992) (28)
- Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-catenin Overexpression and a β-catenin Mutation (2017) (28)
- Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck (2004) (28)
- Organ preservation with chemoradiation in advanced laryngeal cancer: The problem of generalizing results from randomized controlled trials. (2017) (28)
- Prognostic factors in laryngeal squamous cell carcinoma (2020) (27)
- Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. (2013) (27)
- In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model (2016) (27)
- Association Between Multimodality Neck Treatment and Work and Leisure Impairment: A Disease-Specific Measure to Assess Both Impairment and Rehabilitation After Neck Dissection. (2015) (27)
- Preoperative topical antimicrobial decolonization in head and neck surgery (2012) (27)
- The risk of second primary tumors in head and neck cancer: A systematic review (2019) (27)
- Epigenetic alterations in metastatic cutaneous carcinoma (2015) (26)
- High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma. (2010) (26)
- Pericardial extramedullary haemopoiesis in chronic myelomonocytic leukaemia. (1993) (26)
- Monitoring of revascularized jejunal autografts. (1992) (26)
- Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data. (2016) (26)
- Prioritizing Diversity in Otolaryngology–Head and Neck Surgery: Starting a Conversation (2020) (26)
- Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low‐risk patient as defined by targeted sequencing (2016) (26)
- Clinical and Pathologic Predictors of Recurrence and Survival in Spindle Cell Squamous Cell Carcinoma (2011) (25)
- Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinoma (2013) (25)
- First Place—Resident Basic Science Award 1998: Role of Membrane Type 1-Matrix Metalloproteinase and Gelatinase a in Head and Neck Squamous Cell Carcinoma Invasion in Vitro (1999) (25)
- Circulating CD4‐positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal cancer (2014) (24)
- Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we? (2016) (24)
- Higher Micronutrient Intake Is Associated With Human Papillomavirus-Positive Head and Neck Cancer: A Case-Only Analysis (2011) (24)
- Laryngeal paraganglioma in a patient with multiple head and neck paragangliomas (2005) (24)
- Head and neck squamous cell carcinoma in pregnant women (2013) (24)
- Evaluation of CD44 Variant Expression in Oral, Head and Neck Squamous Cell Carcinomas Using a Triple Approach and its Clinical Significance (2014) (24)
- Clinicopathologic Features of Primary Merkel Cell Carcinoma: A Detailed Descriptive Analysis of a Large Contemporary Cohort (2013) (23)
- IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence1,2 (2016) (23)
- Predictors of severe long-term toxicity after re-irradiation for head and neck cancer. (2016) (23)
- Anti-oxidant treatment enhances anti-tumor cytotoxicity of (-)-gossypol (2008) (22)
- The role of age in treatment‐related adverse events in patients with head and neck cancer: A systematic review (2019) (22)
- Sympathetic paraganglioma as an unusual cause of Horner's syndrome (2001) (22)
- E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma (2016) (22)
- Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus‐associated oropharyngeal squamous cell carcinoma (2019) (21)
- Pseudoaneurysm of the proximal facial artery presenting as oropharyngeal hemorrhage (2001) (21)
- Advanced squamous cell carcinoma of the oropharynx: Efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy (2009) (21)
- In vitro cytokine release profile: Predictive value for metastatic potential in head and neck squamous cell carcinomas (2013) (21)
- Association of tobacco (T) use with risk of distant metastases (DM), tumor recurrence, and death in patients (pts) with HPV-positive (+) squamous cell cancer of the oropharynx (SCCOP). (2016) (20)
- Weekly chemotherapy with radiation versus high‐dose cisplatin with radiation as organ preservation for patients with HPV‐positive and HPV‐negative locally advanced squamous cell carcinoma of the oropharynx (2014) (20)
- Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer (2007) (20)
- Spinal epidural abscess after cervical pharyngoesophageal dilation (2005) (20)
- Head and Neck Malignancies (2003) (20)
- Esophagogastroduodenoscopy by family physicians: a national multisite study of 717 procedures. (1990) (19)
- Hypothyroidism and Wound Healing After Salvage Laryngectomy (2018) (19)
- Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer (2013) (19)
- Tissue‐preserving approach to extracting DNA from paraffin‐embedded specimens using tissue microarray technology (2007) (19)
- Olfactory neuroblastoma associated with Kallman's syndrome. (1992) (19)
- In vitro Effects of the BH 3 Mimetic , ( )-Gossypol , on Head and Neck Squamous Cell Carcinoma Cells (2004) (19)
- Classification of TP53 mutations and HPV predict survival in advanced larynx cancer (2016) (19)
- Head and Neck Cancer Stem Cells (2013) (19)
- Esophagogastroduodenoscopy by family physicians phase II: a national multisite study of 2,500 procedures. (1993) (18)
- Is sentinel lymph node biopsy the standard of care for cutaneous head and neck melanoma? (2015) (18)
- Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma (2014) (18)
- NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas (2015) (18)
- Positron emission tomography–CT prediction of occult nodal metastasis in recurrent laryngeal cancer (2017) (18)
- An unusual cause of recurrent pediatric neck abscess: pyriform sinus fistula. (2007) (17)
- New Age Mentoring and Disruptive Innovation-Navigating the Uncharted With Vision, Purpose, and Equity. (2021) (17)
- NCCN Guidelines implementation in the multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan. (2014) (17)
- Tension Pneumocephalus after Endoscopic Sinus Surgery (1994) (17)
- Influence of study sponsorship on head and neck cancer randomized trial results (2012) (17)
- Chemotherapy alone for organ preservation in advanced laryngeal cancer (2009) (17)
- Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation. (2016) (17)
- Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers (2018) (17)
- A novel approach to biomarker discovery in head and neck cancer using an autoantibody signature (2013) (17)
- Novel method of cell line establishment utilizing fluorescence‐activated cell sorting resulting in 6 new head and neck squamous cell carcinoma lines (2016) (16)
- Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer (2017) (16)
- Retropharyngeal abscess: pitfalls of plain films and computed tomography. (1997) (15)
- Planned Early Neck Dissection Before Radiation for Persistent Neck Nodes After Induction Chemotherapy (1997) (15)
- Poster 33 Human Papillomavirus Types Important in Progression of Inverted Papilloma (1995) (15)
- The natural history of thin melanoma and the utility of sentinel lymph node biopsy (2017) (15)
- Human papillomavirus–related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor (2015) (14)
- Human Papillomavirus, p16, and Epidermal Growth Factor Receptor Biomarkers and CT Perfusion Values in Head and Neck Squamous Cell Carcinoma (2013) (14)
- The Role of Full-Thickness Scalp Resection for Management of Primary Scalp Melanoma (2012) (14)
- Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma? (2006) (14)
- Controversies in the Workup and Surgical Management of Parotid Neoplasms (2020) (13)
- Assessment of Intraoperative Nerve Monitoring Parameters Associated With Facial Nerve Outcome in Parotidectomy for Benign Disease. (2019) (13)
- Total versus superficial parotidectomy for stage III melanoma (2017) (12)
- Hemangiopericytoma of the Oral Cavity (1996) (12)
- Second Place — Resident Clinical Science Award 1995: Human Papillomavirus Types Important in Progression of Inverted Papilloma (1995) (12)
- The role of sentinel lymph node biopsy for thin cutaneous melanomas of the head and neck. (2014) (12)
- Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient. (2003) (12)
- Prospective head and neck cancer research: a four-decade bibliometric perspective. (2013) (12)
- The HPV 6 E6/E7 Transforming Genes are Expressed in Inverted Papilloma (1998) (12)
- Spindle Epithelial Tumor with Thymus-Like Differentiation: A Case Report and Review of the Literature (1999) (11)
- Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment. (2016) (11)
- Immune Reactivity Does Not Predict Chemotherapy Response, Organ Preservation, or Survival in Advanced Laryngeal Cancer (2002) (11)
- Pathology quiz case 2. Diagnosis: primary colonic-type adenocarcinoma of the tongue. (2013) (11)
- Speech and swallowing outcomes after laryngectomy for the dysfunctional irradiated larynx (2020) (10)
- Selective neck dissection is an option for early node-positive disease. (2004) (10)
- Stage Migration and Survival Trends in Laryngeal Cancer (2021) (10)
- Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells (2016) (10)
- Expression of Major Histocompatibility Complex Antigens in Squamous Cell Carcinomas of the Head and Neck: Effects of Interferon Gene Transfer (1996) (10)
- Chemo-selection of patients (pts) for organ preservation in advanced laryngeal cancer: Failure of chemotherapy (CT) as the sole treatment for complete histologic responders (CHR) to neoadjuvant chemotherapy. (2006) (9)
- Removing the Taboo on the Surgical Violation (Cut-Through) of Cancer. (2016) (9)
- Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma (2018) (9)
- "My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology Data. (2020) (9)
- Flap monitoring. (1996) (9)
- Management of tonsil cancer (1999) (9)
- Tumor Biomarkers in Spindle Cell Variant Squamous Cell Carcinoma of the Head and Neck (2016) (8)
- Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma (2018) (8)
- Osteocutaneous Free Tissue Transplantation for Mandibular Osteoradionecrosis (2012) (8)
- Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy (2019) (8)
- Upholding the Tripartite Mission in Times of Crisis: Purpose and Perseverance in the COVID-19 Pandemic (2020) (8)
- Pediatric melanoma and aggressive Spitz tumors: a retrospective diagnostic, exposure and outcome analysis. (2018) (7)
- Patching the Safety Net: Establishing a Free Specialty Care Clinic in an Academic Medical Center (2014) (7)
- UM-SCC-103 (2014) (7)
- Head and Neck Cancer Stem Cells: The Effect of HPV (2012) (7)
- TP53 mutations in head and neck cancer (2022) (7)
- CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy. (2020) (7)
- The current practice of open neck mass biopsy in the diagnosis of head and neck cancer: A retrospective cohort study (2019) (7)
- Patient and Provider Perspectives Regarding Enrollment in Head and Neck Cancer Research (2019) (7)
- The care of the head and neck cancer patient is a team sport. (2013) (6)
- Ethics of Frey syndrome: Ensuring that consent is truly informed (2010) (6)
- Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation. (2021) (6)
- Expression of p 53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal Cancer (2008) (6)
- One cycle of induction chemotherapy (IC) in advanced oropharyngeal cancer (SCCOP) to select patients for organ preservation (OP) (2005) (6)
- Neck spasm after chemoradiotherapy for head and neck cancer: Natural history and dosimetric correlates (2014) (6)
- Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era (2021) (6)
- Implementation of a novel otolaryngology clinic for indigent patients (2013) (6)
- When is chemotherapy in head and neck squamous cell carcinoma not indicated? (2015) (6)
- Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis (2015) (5)
- Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx (2017) (5)
- T4 Laryngeal Cancer With Good Function: Should We Be Reluctant to Treat Without Surgery? (2018) (5)
- Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapy. (2010) (5)
- Airway obstruction secondary to central line intravenous fluid extravasation. (1994) (5)
- Expression of Human Papillomavirus 6 in Inverted Papilloma Arising in a Renal Transplant Recipient (1998) (5)
- Use of Cross-Sectional Imaging in Predicting Facial Nerve Sacrifice during Surgery for Parotid Neoplasms (2004) (5)
- High Frequency of HPV-Associated Nasopharyngeal Carcinoma (NPC) in North American Patients: Association With Poor Prognosis (2013) (5)
- Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety (2020) (5)
- Pharyngitis in Adults (2010) (4)
- Longitudinal changes in physical activity of head and neck squamous cell carcinoma patients. (2013) (4)
- Honesty and Transparency, Indispensable to the Clinical Mission-Part III: How Leaders Can Prevent Burnout, Foster Wellness and Recovery, and Instill Resilience. (2022) (4)
- Honesty and Transparency, Indispensable to the Clinical Mission-Part II: How Communication and Resolution Programs Promote Patient Safety and Trust. (2022) (4)
- Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio12 (2014) (4)
- Cranial nerve outcomes in regionally recurrent head & neck melanoma after sentinel lymph node biopsy (2020) (4)
- Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy (2020) (4)
- Impact of Completion Lymphadenectomy on Quality of Life for Head and Neck Cutaneous Melanoma (2021) (3)
- Chemo-selection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma (2007) (3)
- Honesty and Transparency, Indispensable to the Clinical Mission-Part I: How Tiered Professionalism Interventions Support Teamwork and Prevent Adverse Events. (2022) (3)
- Paranasal sinus malignancies (2002) (3)
- Patient burden with current surveillance paradigm and factors associated with interest in altered surveillance for early stage HPV-related oropharyngeal cancer. (2021) (3)
- A randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor. (2019) (3)
- Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin (2020) (3)
- Abstract 2720: Cidofovir modulates HPV E6 and E7 as well as p53, Rb and MDM2 in HPV16 naturally transformed head and neck squamous cell carcinoma and enhances chemosensitivity to Cisplatin (2011) (2)
- Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection (2021) (2)
- Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck. (2007) (2)
- HPV-POSITIVE/P16-POSITIVE/EBV-NEGATIVE (2010) (2)
- Work-Life Balance Among Head and Neck Surgeons-Seeking Visionary Leadership From Everywhere. (2019) (2)
- Implementation of an Intramural Competitive Resident Research Grant (2017) (2)
- Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery. (2020) (2)
- Phase II trial evaluating axitinib for patients with unresectable, recurrent, or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). (2014) (2)
- Phase II trial of cetuximab and radiation in low risk, HPV positive patients with locally advanced squamous cell carcinoma of the oropharynx (SCCOP). (2016) (2)
- Sponsorship and Negotiation for Women Otolaryngologists at Midcareer: A Content Analysis. (2022) (2)
- Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy (2019) (2)
- Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation (2009) (2)
- Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer (2016) (1)
- P186 p53 and Bcl-xL Expression Predicts Outcome in Patients With Oropharynx Cancer Treated With Chemoradiation (2006) (1)
- Association of low neutrophil-to-lymphocyte ratios (NLR) and high lymphocyte-to-monocyte ratios (LMR) with overall survival and response to induction chemotherapy (IC) when used to select patients (pts) with locally advanced squamous cell of the larynx (LSCC) for combined chemoradiation (CRT). (2019) (1)
- Patching the Safety Net: Establishing a Free Specialty Care Clinic in an Academic Medical Center (2014) (1)
- A retrospective study to determine the utility of measuring E6 and E7 antibody (Ab) levels in sera as a biomarker of recurrence in patients (pts) with locally advanced (LA), human papillomavirus-positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). (2014) (1)
- Decision Making for Diagnosis and Management: A Consensus Comes to Life. (2017) (1)
- Phase 2 Trial of AT-101 in Combination With Docetaxel for Recurrent, Locally Advanced, or Metastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC) (2014) (1)
- The Management of Head and Neck Melanoma and Advanced Cutaneous Malignancies (2010) (1)
- Circulating Tumor HPV DNA Characteristics in High Risk Oropharyngeal Squamous Cell Carcinoma (2020) (1)
- Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines (2020) (1)
- Head and Neck Squamous Cell Carcinoma in Pregnant Women (2011) (1)
- Feeding tube placement facilitates aggressive hyperfractionated chemoradiation (HXCRT) for unresectable head and neck cancer (2004) (1)
- Anesthesia for Otolaryngologic Surgery: Anesthesia for neck dissection and laryngectomy (2012) (1)
- Genetic markers of head and neck cancer: identifying new molecular targets. (2003) (1)
- Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma (2022) (1)
- Capecitabine after Surgical Salvage in Recurrent Squamous Cell Carcinoma of Head and Neck (2017) (1)
- HPV-Associated Oropharyngeal Cancer Tumor Board (2011) (1)
- Chemoselection with induction chemotherapy followed by chemoradiation or surgery versus chemoradiation for patients (pts) with locally advanced squamous cell carcinoma of the oropharynx (LASCCOP). (2011) (1)
- A Phase 2 Study Evaluating Axitinib in Patients With Unresectable, Recurrent, or Metastatic Head and Neck Cancer (2016) (1)
- Targeting p53-mdm2 interaction using a potent mdm2 inhibitor to overcome cisplatin resistance in head and neck squamous cell carcinoma (2007) (1)
- Defining the Young Patient with Oral Cavity Cancer: Phenotypic and Genotypic Analysis (2021) (1)
- Long‐term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index (2021) (1)
- Presidential Research Symposium Advances in Head and Neck Cancer (1999) (0)
- A merican H ead & N eck S ociety 2006 Annual Meeting & Research Workshop on the Biology, Prevention and Treatment of Head & Neck Cancer (2006) (0)
- Session B: Head and Neck/Larynx (Room 105—SFMC): Differential Expression and Regulation of Immune Co-Stimulatory Antigen Ly-6A/E Following Malignant Transformation and Immune Escape of Murine SCC Pam212 (1997) (0)
- Abstract 57: Human papillomavirus-16 DNA methylation in head and neck squamous cell carcinomas. (2012) (0)
- Abstract 2642: Dietary intake is associated with tumor suppressor DNA methylation in head and neck squamous cell carcinomas (2012) (0)
- Indications and Caveats (2016) (0)
- Abstract 480: Targeting cancer stem cells through STAT3 inhibition in head and neck cancers (2011) (0)
- Rap1Stabilizesβ-Catenin andEnhances β-Catenin–Dependent Transcription and Invasion in Squamous Cell Carcinoma of the Head and Neck (2009) (0)
- Low neutrophil to lymphocyte & high lymphocyte to monocyte ratios associated with improved overall survival & response to induction chemotherapy when selecting patients with locally advanced squamous cell of the larynx for combined chemoradiation (2020) (0)
- Matted Lymph Nodes: An Indication for Intensification of Chemotherapy in Human Papillomavirus–Related (HPV+) Oropharyngeal Cancer (OPC)? (2014) (0)
- Metabolic abnormalities associated with wt loss during chemo-RT of HN cancer (2005) (0)
- Genetics of Head and Neck Cancer: Advances in Molecular Research (1995) (0)
- S16 Multidisciplinary treatment and the development of future strategies: the cancer biologist as a team member (2007) (0)
- Induction chemotherapy for organ preservation versus surgery for advanced oral cavity squamous cell carcinoma (OCSCC). (2012) (0)
- Abstract 19: Establishment of an upstream head and neck precision oncology tumor board (2017) (0)
- Fistula Rate after Salvage Laryngectomy with Aggressive Levothyroxine Replacement, A Prospective Phase 2 Clinical Trial (2020) (0)
- Impact of extrinsic tongue muscle invasion on stage migration in AJCC 8th edition staging of oral cavity carcinoma. (2020) (0)
- Expression of p53 and Bcl-xL predicts outcome in patients with advanced squamous cell carcinoma of oropharynx treated with chemoradiation for organ preservation (2006) (0)
- Prospective Study of Voice and Speech Quality After Chemo-IMRT for Oropharyngeal Cancer: Clinical and Dosimetric Predictors and Differences Between Patient and Observer Reporting (2014) (0)
- S110 (−)-Gossypol, a BH3 Mimetic and Inducer of Apoptosis in Head and Neck Cancer Cells, Is Oxidized and Deactivated by ROS (2006) (0)
- Imaging response versus operative laryngoscopy assessment of induction chemotherapy response in an induction bioselection approach to larynx cancer (2020) (0)
- PD.26 Neck dissection impairment index: Adisease specific measure used to perform a cross-sectional study to evaluate impairment and rehabilitation after neck dissection (2005) (0)
- Roles of Clinical and Image-Based Features for Outcomes in Larynx Cancer Patients (2020) (0)
- Abstract 30: Small molecule profiling uncovers the landscape of combinatorial PI3K inhibitor responses in HNSCC (2017) (0)
- Prognostic biomarkers in squamous cell carcinoma of the head and neck (2013) (0)
- Comparison of the 7 th and 8 th Editions of the AJCC/UICC Staging for Human Papillomavirus–Related Oropharynx Carcinoma (2018) (0)
- Miniseminar: Making Therapeutic Decisions About Head and Neck Cancer: Operative and Nonoperative Options (2005) (0)
- Cervical Osteoradionecrosis: A New Syndrome Affecting Survivors of Head-and-Neck Cancer Years After Chemoradiation (2014) (0)
- P100 Genetic Alterations in p53 in Head and Neck Cancer Cell Lines Change Cisplatin Sensitivity (2006) (0)
- A phase II trial of tetrathiomolybdate (TM) in metastatic head & neck cancer (MHNC) patients (pts) after treatment with platinum & 5-fluorouracil (P&5FU) (2008) (0)
- 2018 Distinguished Service Award Winners (2018) (0)
- Sponsorship in Otolaryngology-Head and Neck Surgery: A Pathway to Equity, Diversity, and Inclusion. (2023) (0)
- Abstract 322: Discovery of synergistic PI3K inhibitor combination therapies using high throughput approaches in HNSCC (2019) (0)
- S031 Survivin in Cisplatin-Induced Cell Death in Head and Neck Squamous Cell Carcinomas (HNSCC) (2006) (0)
- The American board of otolaryngology (1934) (0)
- Abstract 4092: Targeting compensatory mechanisms of resistance to phosphatidylinositol 3-kinase inhibitors in head and neck squamous cell carcinoma (2017) (0)
- ASO Visual Abstract: Stage Migration and Survival Trends in Laryngeal Cancer (2021) (0)
- Use of colony stimulating factors for the treatment of drug-induced agranulocytosis. (1993) (0)
- Differential tumor and normal mucosa biomarker modulation by epidermal growth factor receptor (EGFR) inhibition using erlotinib in oral cavity squamous cell carcinoma (OCSCC). (2009) (0)
- P119 CD24 Expression Correlates With Response to Cisplatin in Head and Neck Squamous Cell Carcinoma Cell Lines (2006) (0)
- Mutational Profiles of Recurrent Laryngeal Squamous Cell Carcinoma (2018) (0)
- Radiation C oncurrent W ith G emcitabine f or L ocally Advanced H ead a nd N eck C ancer: A P hase I T rial a nd Intracellular D rug I ncorporation S tudy (2001) (0)
- Clinical Review (0)
- Outcomes related to biomarkers in organ preservation for patients with advanced squamous cell carcinoma of the oral cavity (SCCOC). (2010) (0)
- The Value of Positron Emission Tomography–Computed Tomography in Predicting Occult Nodal Metastasis in Recurrent Laryngeal Cancer (2016) (0)
- Operational Constraints and Gender Biases: A Qualitative Analysis of Physician Parenting Experiences (2022) (0)
- Defining the Young Oral Cavity Cancer Patient (2018) (0)
- Regulation of Resistance to Cisplatin in Human Squamous Cell Carcinoma Cell Lines (1997) (0)
- Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16‐positive oropharynx cancer (2023) (0)
- Poster 38 High-Risk Human Papilloma Virus Types and Squamous Cell Carcinoma in Patients with Respiratory Papillomas (1995) (0)
- Incidental masticator space lesion in a teenager. (2015) (0)
- Metabolic consequences of weight (WT) loss during concurrent chemoirradiation of head and neck (HN) cancer (2004) (0)
- Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials (2021) (0)
- Abstract 814:NOTCH1regulates head and neck cancer cell growth and invasion (2017) (0)
- Genetics of Head and Neck Cancer (Introduction) (1995) (0)
- Phase II prospective trial of cetuximab and radiotherapy for locally advanced, squamous cell carcinomas of the head and neck in patients >70 years old or with comorbidities not-eligible for platinum-based chemotherapy. (2016) (0)
- PD.237 Leech therapy for the salvage ofrevascularized free tissue transfer with surgically unsalvageable venous obstruction (2005) (0)
- Is There a Difference in Staging and Treatment of Head and Neck Squamous Cell Tumors Between Tertiary Care and Community‐Based Institutions? (2018) (0)
- Kaplan-Meier survival curves depicting three year survival for each of the six clusters identified via unsupervised hierarchical cluster analysis. (2013) (0)
- 10:32: Tracheoesophageal Puncture Following Chemoradiation (2007) (0)
- PD23 Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer (2007) (0)
- In brief (1978) (0)
- Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl‐xL inhibitor (2022) (0)
- Risks and Benefits of DVT/PE Prophylaxis in Otolaryngology (2011) (0)
- Head and Neck Skin Cancer: When Mohs Is Not Enough (2013) (0)
- PD.199 Prospective study of selective neck dissection for the control of neck metastasis from squamous cell carcinoma of the upper aerodigestive tract (2005) (0)
- Abstract A86: Higher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: A case-only analysis (2010) (0)
- Response to comments by Panizza et al. on article “Cutaneous head and neck basal and squamous cell carcinoma with perineural invasion” by Mendenhall et al. (2012) (0)
- Poster 4: Expression of Major Histocompatibility Complex Antigens in Squamous Cell Carcinomas of the Head and Neck: Effects of Interferon Gene Transfer (1996) (0)
- The Health Impact of Head and Neck Cancer (1997) (0)
- Spindle Cell Variant of Squamous Cell Carcinoma (2010) (0)
- Poor Survival in Low N-Stage Squamous Cell Carcinoma Metalloproteinase 9 Secretion , Which Is Associated with Rap 1 GAP Promotes Invasion via Induction of Matrix (2008) (0)
- PCNA and EGFR together identify disease specific survival probability in advanced oropharynx cancer patients treated on an organ sparing protocol (2007) (0)
- Retrospective review of capecitabine as adjuvant therapy in high risk or recurrent squamous cell carcinoma of head and neck (SCCHN). (2015) (0)
- Dysphagia and aspiration following radiation concurrent with chemotherapy (chemo-RT) for head and neck cancer: prospective study (2001) (0)
- Bcl-2 and bcl-XL protein expression for organ preservation in advanced laryngeal cancers (1999) (0)
- Methylation contributes to decreased Smac expression and resistance to cisplatin-induced apoptosis in head and neck squamous cell carcinomas (2007) (0)
- Clinicopathologic Review of Mucoepidermoid Carcinoma (2011) (0)
- Head and neck oncologic surgery (2007) (0)
- Practice Management Considerations for the Otolaryngologist (2006) (0)
- Head and Neck Cutaneous Melanoma: A 2012 Update (2012) (0)
- Treatment of laryngeal cancer: The University of Michigan experience. (2016) (0)
- Head and Neck Cancer: Emerging Perspectives (2004) (0)
- Abstract 3712: Mechanistic link between phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) activity and PDL1 expression in head and neck squamous cell carcinoma (HNSCC) (2017) (0)
- NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas (2015) (0)
- In reply: Management of thin melanoma (2018) (0)
- Professional Advancement: Why Gender Differences Matter (2012) (0)
- Impact of AJCC 8th Edition Clinical T- and N-Classifications on Oncologic Outcomes and Patterns of Failure in HPV-Related Oropharyngeal Carcinoma (2018) (0)
- Abstract 3940: Small molecule profiling uncovers the landscape uncovers the landscape of combinational PI3K inhibitor responses in HNSCC (2018) (0)
- 11:00 AM: Expression of HPV 6 E6/E7 Transforming Genes in Nasal Inverted Papilloma (1996) (0)
This paper list is powered by the following services:
Other Resources About Carol R. Bradford
What Schools Are Affiliated With Carol R. Bradford?
Carol R. Bradford is affiliated with the following schools:
